Gambaran Umum
Ang ME Therapeutics Holdings Inc., na nakabase sa Estados Unidos, ay nagpapatakbo sa loob ng sektor ng biotechnology, na pangunahing nakatuon sa pagbuo at komersyalisasyon ng mga nobelang therapeutics sa oncology. Kasama sa pipeline ng kumpanya ang mga cutting-edge na proyekto na nagta-target sa iba't ibang mga kanser sa pamamagitan ng mga makabagong mekanismo tulad ng mga small molecule inhibitors at immune modulators. Ang mga pangunahing proyekto nito ay karaniwang naglalayong tugunan ang mga hindi natutugunan na mga klinikal na pangangailangan sa pamamagitan ng pagpapabuti ng pagiging epektibo at pagbabawas ng mga side effect ng mga paggamot sa kanser. Ang ME Therapeutics Holdings Inc. ay nakatuon sa paggamit ng mga siyentipikong pagsulong upang isulong ang mga therapeutic na kandidato nito mula sa pagtuklas hanggang sa mga klinikal na pagsubok, na nagpapakita ng pangako nito sa makabuluhang epekto sa pangangalaga ng pasyente sa espasyo ng oncology.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk ME Therapeutics Holdings Inc. per 2025 May 31 adalah -1.20 MM.
- Nilai net income untuk ME Therapeutics Holdings Inc. per 2025 May 31 adalah -1.17 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-05-31 | -1.20 | -1.17 | |
| 2025-02-28 | -1.38 | -1.31 | |
| 2024-11-30 | -1.32 | -1.25 | |
| 2024-08-31 | -1.37 | -1.29 | |
| 2024-05-31 | -1.44 | -1.37 | |
| 2024-02-29 | -1.42 | -6.93 | |
| 2023-11-30 | -1.31 | -6.82 | |
| 2023-08-31 | -0.98 | -6.52 | |
| 2023-05-31 | -0.67 | -6.21 | |
| 2022-08-31 | -0.15 | -0.15 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-05-31 | ||
| 2025-02-28 | ||
| 2024-11-30 | -0.05 | -0.05 |
| 2024-08-31 | -0.05 | -0.05 |
| 2024-05-31 | -0.06 | -0.07 |
| 2024-02-29 | -0.28 | -0.29 |
| 2023-11-30 | -0.35 | -0.35 |
| 2023-08-31 | -0.42 | -0.42 |
| 2023-05-31 | -0.40 | -0.40 |
| 2022-08-31 | -0.02 | -0.02 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk ME Therapeutics Holdings Inc. per 2025 May 31 adalah -0.77 MM.
- Nilai cash from investing activities untuk ME Therapeutics Holdings Inc. per 2025 May 31 adalah -0.24 MM.
- Nilai kas dari aktivitas pendanaan untuk ME Therapeutics Holdings Inc. per 2025 May 31 adalah 1.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-05-31 | -0.77 | -0.24 | 1.00 |
| 2025-02-28 | -0.65 | -0.17 | 1.47 |
| 2024-11-30 | -0.54 | -0.02 | 1.50 |
| 2024-08-31 | -0.66 | 1.51 | |
| 2024-05-31 | -0.61 | 0.00 | 1.63 |
| 2024-02-29 | -0.61 | 0.76 | 1.18 |
| 2023-11-30 | -0.53 | 0.76 | 0.12 |
| 2023-08-31 | -0.30 | 0.76 | 0.12 |
| 2023-05-31 | -0.24 | 0.76 | 0.00 |
| 2022-08-31 | -0.14 | 0.14 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-05-31 | |||
| 2025-02-28 | |||
| 2024-11-30 | |||
| 2024-08-31 | |||
| 2024-05-31 | |||
| 2024-02-29 | |||
| 2023-11-30 | |||
| 2023-08-31 | |||
| 2023-05-31 | |||
| 2022-08-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-05-31 | ||
| 2025-02-28 | ||
| 2024-11-30 | ||
| 2024-08-31 | ||
| 2024-05-31 | ||
| 2024-02-29 | ||
| 2023-11-30 | ||
| 2023-08-31 | ||
| 2023-05-31 | ||
| 2022-08-31 |
Efektivitas Manajemen
- roic untuk ME Therapeutics Holdings Inc. pada 2025 May 31 adalah -0.57.
- croic untuk ME Therapeutics Holdings Inc. pada 2025 May 31 adalah 0.28.
- ocroic untuk ME Therapeutics Holdings Inc. pada 2025 May 31 adalah -0.28.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-05-31 | -0.57 | 0.28 | -0.28 | ||
| 2025-02-28 | -2.66 | -0.87 | 0.66 | -0.37 | |
| 2024-11-30 | |||||
| 2024-08-31 | |||||
| 2024-05-31 | |||||
| 2024-02-29 | 0.00 | ||||
| 2023-11-30 | 0.00 | 0.89 | |||
| 2023-08-31 | -63.64 | ||||
| 2023-05-31 | |||||
| 2022-08-31 | -2.39 | 0.07 | -2.22 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-05-31 | |||
| 2025-02-28 | |||
| 2024-11-30 | |||
| 2024-08-31 | |||
| 2024-05-31 | |||
| 2024-02-29 | |||
| 2023-11-30 | |||
| 2023-08-31 | |||
| 2023-05-31 | |||
| 2022-08-31 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
